SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-19-017514
Filing Date
2019-09-09
Accepted
2019-09-09 16:47:56
Documents
2
Period of Report
2019-09-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k090419_wizepharmainc.htm 8-K 24995
2 PRESS RELEASE, DATED SEPTEMBER 9, 2019: "WIZE PHARMA ENTERS EXCLUSIVE LICENSE AG f8k090419ex99-1_wizepharma.htm EX-99.1 24564
  Complete submission text file 0001213900-19-017514.txt   50874
Mailing Address 24 HANAGAR ST HOD HASHARON L3 4527713
Business Address 24 HANAGAR ST HOD HASHARON L3 4527713 972 472 260 0536
Wize Pharma, Inc. (Filer) CIK: 0001218683 (see all company filings)

IRS No.: 880445167 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-52545 | Film No.: 191083527
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1